10,394
Views
23
CrossRef citations to date
0
Altmetric
Poison Centre Research

Trends in gabapentin and baclofen exposures reported to U.S. poison centers

, , , , &
Pages 763-772 | Received 19 Jul 2019, Accepted 29 Oct 2019, Published online: 01 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Phillip Hughes & Bayla Ostrach. (2021) Trends in exposure to over-reach: a comment on the methodology of Reynolds et al. 2019 . Clinical Toxicology 59:1, pages 85-86.
Read now

Articles from other publishers (22)

Jean-Marc Pelerin, Lisa Fristot, Valérie Gibaja, Bruno Revol, Pierre Gillet & Juliana Lima-Tournebize. (2023) Non-medical use of baclofen: A case series and review of the literature. Therapies 78:6, pages 615-637.
Crossref
Osman Syed, Predrag Jancic, Adam B. Fink & Nebojsa Nick Knezevic. (2023) Drug Safety and Suicidality Risk of Chronic Pain Medications. Pharmaceuticals 16:10, pages 1497.
Crossref
Matthew J. McLaughlin & Mark T. Fisher. (2023) A critical evaluation of oral baclofen in pediatric patients with cerebral palsy. Journal of Pediatric Rehabilitation Medicine 16:1, pages 3-9.
Crossref
Olga L. Romanova, Arkady M. Golubev, Alexey A. Churilov, Dmitriy V. Sundukov, Maksim A. Kislov & Anton V. Ershov. (2022) Damage to neurons of the cerebral cortex in acute poisoning with baclofen and its combination with ethanol. Russian Journal of Forensic Medicine 8:4, pages 15-24.
Crossref
Carolyn J. Gibson, Yixia Li, Guneet K. Jasuja, Salomeh Keyhani & Amy L. Byers. (2022) Long-term Psychoactive Medications, Polypharmacy, and Risk of Suicide and Unintended Overdose Death Among Midlife and Older Women Veterans. Journal of General Internal Medicine 37:S3, pages 770-777.
Crossref
Christine L. Mattson, Farnaz Chowdhury & Thomas P. Gilson. (2022) Notes from the Field: Trends in Gabapentin Detection and Involvement in Drug Overdose Deaths — 23 States and the District of Columbia, 2019–2020 . MMWR. Morbidity and Mortality Weekly Report 71:19, pages 664-666.
Crossref
Zoe A Karavolis, Andrew B Su & Alyssa M Peckham. (2022) State-level response to gabapentin misuse in the United States: Implications and future direction. American Journal of Health-System Pharmacy 79:9, pages e143-e148.
Crossref
Steven E. Epstein, Kate Hopper & Kate S. Farrell. (2022) Manual plasma exchange to treat an accidental overdose of intravenous lipid emulsion in a dog with baclofen toxicosis. Journal of the American Veterinary Medical Association 260:6, pages 650-656.
Crossref
Josée Bouchard, Christopher Yates, Diane P. Calello, Sophie Gosselin, Darren M. Roberts, Valéry Lavergne, Robert S. Hoffman, Marlies Ostermann, Ai Peng, Marc Ghannoum, Badria Alhatali, Kurt Anseeuw, Steven Bird, Ingrid Berling, Timothy E. Bunchman, Paul K. Chin, Kent Doi, Tais Galvao, David S. Goldfarb, Hossein Hassanian, Lotte C.G. Hoegberg, Siba Kallab, Sofia Kebede, Jan T. Kielstein, Andrew Lewington, Etienne M. Macedo, Rob MacLaren, Bruno Megarbane, James B. Mowry, Thomas D. Nolin, Jean-Philippe Roy, Anitha Vijayan, Steven J. Walsh, Anselm Wong & David M. Wood. (2022) Extracorporeal Treatment for Gabapentin and Pregabalin Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. American Journal of Kidney Diseases 79:1, pages 88-104.
Crossref
Katherine Hadlandsmyth, Nancy C. Bernardy & Brian C. Lund. (2022) Central nervous system polytherapy among veterans with posttraumatic stress disorder: changes across a decade. General Hospital Psychiatry 74, pages 46-50.
Crossref
Shaun Aindow, Rose Crossin, Les Toop & Ben Hudson. (2021) Managing the misuse potential and risk of psychological harm from gabapentinoids in primary care in New Zealand. Journal of Primary Health Care 13:4, pages 302-307.
Crossref
Nazleen F. Khan, Katsiaryna Bykov, Robert J. Glynn, Michael L. Barnett & Joshua J. Gagne. (2021) Coprescription of Opioids With Other Medications and Risk of Opioid Overdose. Clinical Pharmacology & Therapeutics 110:4, pages 1011-1017.
Crossref
Megan Pelter, Samantha R. S. Bagsic & Laura Nicholson. (2021) Oral baclofen toxicity in older patients with chronic kidney disease. Journal of the American Geriatrics Society 69:8, pages 2352-2354.
Crossref
Heath B. McAnally & Udo Bonnet. (2021) Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”. Pain and Therapy 10:1, pages 757-762.
Crossref
N. Yu. Porseva, A. V. Soloninina & O. N. Dvorskaya. (2021) STUDY OF PHARMACEUTICAL SPECIALISTS’ INFORMATION AWARENESS ON THE MATTERS OF DRUG ABUSE. Pharmacy & Pharmacology 8:6, pages 456-464.
Crossref
GYeon Oh, Svetla Slavova & Patricia R. Freeman. (2021) Characterization of gabapentin use in Kentucky after reclassification as a Schedule V controlled substance. Journal of the American Pharmacists Association 61:3, pages e86-e92.
Crossref
Megan Maroney & Marija Markovic. 2021. 99 121 .
Katelynn M. Mayberry, Paige S. Brockington, Victoria T. Phan & Sidhartha D. Ray. 2021. 41 69 .
Staffan Hägg, Anna K. Jönsson & Johan Ahlner. (2020) Current Evidence on Abuse and Misuse of Gabapentinoids. Drug Safety 43:12, pages 1235-1254.
Crossref
О. L. Romanova, M. L. Blagonravov & M. A. Kislov. (2020) Baclofen: Therapeutic and Toxic Mechanisms of Action (Review). General Reanimatology 16:4, pages 60-71.
Crossref
Caitlin N. Kent, Charlotte Park & Craig W. Lindsley. (2020) Classics in Chemical Neuroscience: Baclofen. ACS Chemical Neuroscience 11:12, pages 1740-1755.
Crossref
Isobel Clough. (2019) Clinical News. British Journal of Hospital Medicine 80:12, pages 692-695.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.